Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Endometrial Neoplasms 10Endometrial Hyperplasia 5Neoplasms 4Cachexia 4Breast Neoplasms 4Anorexia 4Recurrence 2Vomiting 1Squamous Intraepithelial Lesions 1Spinal Cord Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Optic Nerve Glioma 1Oligodendroglioma 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Medulloblastoma 1Lymphoma 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Hairy Cell 1Leukemia 1Head and Neck Neoplasms 1Fatigue 1Familial ependymoma 1Dendritic Cell Sarcoma, Interdigitating 1Choroid Plexus Neoplasms 1

Interventions

Watchful Waiting 1Vegetables 1Observation 1Megestrol Acetate 1Fruit 1Exercise 1Diet, Fat-Restricted 1Cyproheptadine 1Calcium 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Body Weight Changes × Megestrol Acetate × Clear all
NCT01200602 2015-11-25

Megestrol Acetate in Treating Weight Loss or Anorexia in Young Patients With Malignancies Who Are Undergoing Radiation Therapy and/or Chemotherapy

Mayo Clinic

Phase 2 Terminated
1 enrolled

Anorexia, Body Weight Changes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡